Key facts
- Notable investors include Passion Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SLS Nutraceuticals
- ·The full record, as it builds
Funding rounds
No funding rounds for SLS Nutraceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SLS Nutraceuticals
Developer of brain health products intended to protect aged, stressed, or tired minds and improve cognitive performance. The company's formulations target neuronal lipid damage brought about by stress, lack of sleep, or aging and use a specific combination of natural ingredients known for their brain health qualities, reducing lipid and protein oxidation to improve learning and memory, enabling neuroscientists to leverage the advances in neuroscience to create innovative products that protect and optimize brain function.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Employees
- 6
- Website
- slsnutra.com/
- Ownership
- Privately Held (backing)
SLS Nutraceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SLS Nutraceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SLS Nutraceuticals in its N-PORT filings yet. We sweep new filings monthly.